Anthem Registers 14% Revenue Growth In Q4, Raises Dividend

Anthem Inc ANTM has reported Q4 adjusted EPS of $5.14, more than double from $2.54 a year ago and beating the consensus of $5.11.

  • Operating revenue rose 14.2% to $36 billion, slightly missing expectations of $36.51 billion, driven by higher premium revenue due to growth in Medicaid and Medicare and pharmacy product revenue related to IngenioRx.
  • The benefit expense ratio was 89.5%, an increase of 60 basis points versus the prior-year quarter and a decrease of 90 basis points after adjusting for the repeal of the health insurance tax in 2021. 
  • Operating cash flow was $1.7 billion, or 1.5 times net income, a decrease of $2.1 billion when compared year-over-year.
  • Medical enrollment increased 5.7% Y/Y to 45.4 million members. Government Business enrollment increased by 2.2 million lives, primarily driven by organic growth in the Medicaid business.
  • Dividend: Anthem increased the quarterly dividend by 13% to $1.28 per share, payable on March 25, with a record date of March 10.
  • FY22 Outlook: Anthem expects operating revenue of approximately $152 billion, including premium revenue of roughly $130 billion.
  • The company sees adjusted EPS of more than $28.25 versus the consensus of $28.66.
  • It anticipates operating cash flow to be greater than $6.9 billion.
  • Anthem expects 45.6 - 46.2 million medical membership, a risk-based membership of 19.5 - 19.9 million, and a fee-based membership of 26.1 - 26.3 million.
  • Price Action: ANTM shares closed lower by 2.30% at $439.18 on Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsGuidanceDividendsHealth CareGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!